IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $741,364 | +10.3% | 16,344 | -0.2% | 0.00% | +50.0% |
| Q2 2023 | $672,236 | +28.4% | 16,384 | +11.9% | 0.00% | 0.0% |
| Q1 2023 | $523,377 | -5.4% | 14,644 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $553,104 | -15.8% | 14,644 | -1.3% | 0.00% | -33.3% |
| Q3 2022 | $657,000 | +21.4% | 14,844 | +1.6% | 0.00% | +50.0% |
| Q2 2022 | $541,000 | -0.9% | 14,607 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $546,000 | +24.1% | 14,728 | +1.8% | 0.00% | +100.0% |
| Q4 2021 | $440,000 | -9.7% | 14,464 | -0.3% | 0.00% | -50.0% |
| Q3 2021 | $487,000 | +18.8% | 14,514 | +41.1% | 0.00% | +100.0% |
| Q2 2021 | $410,000 | -18.3% | 10,288 | -7.8% | 0.00% | -50.0% |
| Q1 2021 | $502,000 | -41.4% | 11,164 | -26.4% | 0.00% | -33.3% |
| Q4 2020 | $857,000 | +19.5% | 15,164 | +0.3% | 0.00% | 0.0% |
| Q3 2020 | $717,000 | -22.1% | 15,119 | -3.2% | 0.00% | -25.0% |
| Q2 2020 | $921,000 | +20.9% | 15,618 | -3.1% | 0.00% | -20.0% |
| Q1 2020 | $762,000 | -22.7% | 16,111 | -1.3% | 0.01% | 0.0% |
| Q4 2019 | $986,000 | +12.9% | 16,320 | +11.9% | 0.01% | 0.0% |
| Q3 2019 | $873,000 | -4.2% | 14,578 | +2.8% | 0.01% | 0.0% |
| Q2 2019 | $911,000 | -23.5% | 14,176 | -3.4% | 0.01% | -28.6% |
| Q1 2019 | $1,191,000 | +52.1% | 14,669 | +1.2% | 0.01% | +16.7% |
| Q4 2018 | $783,000 | +4.8% | 14,490 | +0.1% | 0.01% | +20.0% |
| Q3 2018 | $747,000 | +23.9% | 14,476 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $603,000 | +132.8% | 14,476 | +146.4% | 0.00% | +100.0% |
| Q1 2018 | $259,000 | -19.1% | 5,876 | -7.5% | 0.00% | 0.0% |
| Q4 2017 | $320,000 | +15.5% | 6,354 | +16.5% | 0.00% | 0.0% |
| Q3 2017 | $277,000 | +1.1% | 5,454 | +1.4% | 0.00% | 0.0% |
| Q2 2017 | $274,000 | +6.2% | 5,381 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $258,000 | +0.4% | 5,381 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $257,000 | +17.4% | 5,381 | -0.7% | 0.00% | 0.0% |
| Q1 2016 | $219,000 | -38.0% | 5,417 | -5.2% | 0.00% | -33.3% |
| Q4 2015 | $353,000 | – | 5,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |